Mark W. Kroll's most recent trade in Haemonetics Corp. was a trade of 2,207 Common Stock done . Disclosure was reported to the exchange on July 25, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Haemonetics Corp. | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 20,664 (0%) | 0% | - | Common Stock | |
| Haemonetics Corp. | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 18,457 (0%) | 0% | - | Common Stock | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 993 | 11,135 (0%) | 0% | 0 | Common Stock | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 220.72 per share. | 07 Mar 2023 | 3,457 | 10,142 (0%) | 0% | 220.7 | 763,043 | Common Stock |
| Axon Enterprise Inc | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 220.85 per share. | 07 Mar 2023 | 92 | 13,599 (0%) | 0% | 220.8 | 20,318 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 73.71 per share. | 15 Aug 2022 | 8,016 | 16,231 (0%) | 0% | 73.7 | 590,859 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 24,247 (0%) | 0% | - | Common Stock | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 102.82 per share. | 08 Jun 2022 | 3,159 | 13,691 (0%) | 0% | 102.8 | 324,796 | Common Stock |
| Axon Enterprise Inc | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 99.40 per share. | 20 May 2022 | 2,013 | 16,850 (0%) | 0% | 99.4 | 200,092 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 21,517 (0%) | 0% | - | Common Stock | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 139.48 per share. | 27 May 2021 | 1,434 | 14,837 (0%) | 0% | 139.5 | 200,014 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 55.10 per share. | 26 May 2021 | 11,813 | 18,440 (0%) | 0% | 55.1 | 650,896 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.50 per share. | 26 May 2021 | 10,353 | 30,253 (0%) | 0% | 35.5 | 367,557 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 10,353 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 124.94 per share. | 12 May 2021 | 4,204 | 13,403 (0%) | 0% | 124.9 | 525,260 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Apr 2021 | 334 | 20,067 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Mark W. Kroll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Apr 2021 | 167 | 19,900 (0%) | 0% | 0 | Common Stock | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Jan 2021 | 1,000 | 17,607 (0%) | 0% | 0 | Common Stock | |
| Axon Enterprise Inc | Mark W. Kroll | Director | Sale of securities on an exchange or to another person at price $ 120.44 per share. | 16 Nov 2020 | 2,993 | 18,607 (0%) | 0% | 120.4 | 360,477 | Common Stock |
| Haemonetics Corp. | Mark W. Kroll | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 1,983 | 20,401 (0%) | 0% | - | Common Stock |